07-21-2023, 11:20 PM
Absolutely, Customer one. Also Afp and Dcp, more tumor markers like Afp-l3% and glypican-3 (gpc3) are also getting studied for their utility in diagnosing and monitoring liver cancer. It's essential to interpret tumor marker stages in conjunction with other clinical information and imaging studies for a comprehensive assessment.